(4aS,6aR,13aR,13bS)-4,4,6a,13b-tetramethyl-1,3,4,4a,5,6,6a,13,13a,13b-decahydro-2H-benzo[a][1,3]dioxolo[4,5-i]xanthene | 257288-53-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: (4aS,6aR,13aR,13bS)-4,4,6a,13b-tetramethyl-1,3,4,4a,5,6,6a,13,13a,13b-decahydro-2H-benzo[a][1,3]dioxolo[4,5-i]xanthene
• 英文别名: 8-epi-19,20-di-O-methylenepuupehenol；8-epi-19,20-O-methylene-puupehenol；(1R,13R,14S,19S)-1,14,18,18-tetramethyl-2,6,8-trioxapentacyclo[11.8.0.03,11.05,9.014,19]henicosa-3,5(9),10-triene
• CAS: 257288-53-2
• 化学式: C₂₂H₃₀O₃
• 分子量: 342.478
• InChiKey: SACUDAWUVXNSEM-YUVXSKOASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  25
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4aS,6aR,13aR,13bS)-4,4,6a,13b-tetramethyl-1,3,4,4a,5,6,6a,13,13a,13b-decahydro-2H-benzo[a][1,3]dioxolo[4,5-i]xanthene 在 三(五氟苯基)硼烷 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 1,4-二氧六环 、 正己烷 、 甲苯 为溶剂， 反应 23.0h， 生成 (4aS,6aR,12bS)-4,4,6a,12b-Tetramethyl-9,10-bis-triethylsilanyloxy-1,3,4,4a,5,6,6a,12b-octahydro-2H-benzo[a]xanthene
  参考文献：
  名称：

  用于聚异戊二烯的新型人工环化酶：(-)-Chromazonarol、(+)-8-epi-Puupehedione 和 (-)-11'-Deoxytaondiol 甲基醚的对映选择性全合成

  摘要：

  本文介绍了一种新型人工环化酶，光学纯的 3-o-fluorobenzyloxy-2-hydroxy-2'-(p-methoxybemzyl)-1,1'-binaphthyl.SnCl4，可有效地对映选择性环化 2-(polyprenyl ) 苯酚衍生物，提供带有色满骨架的多环萜类化合物，例如 (-)-chromazonarol、(+)-8-epi-puupehedione、(+)-wiedendiol 的关键合成中间体和 (-)-11'-deoxytaondiolmethyl醚。

  DOI：

  10.1021/ja0472026
• 作为产物：
  描述：

  (-)-补身醇 在 camphor-10-sulfonic acid 、 叔丁基锂 、 镍 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 、 正戊烷 为溶剂， 反应 16.5h， 生成 (4aS,6aR,13aR,13bS)-4,4,6a,13b-tetramethyl-1,3,4,4a,5,6,6a,13,13a,13b-decahydro-2H-benzo[a][1,3]dioxolo[4,5-i]xanthene
  参考文献：
  名称：

  First Enantiospecific Synthesis of the Antitumor Marine Sponge Metabolite (−)-15-Oxopuupehenol from (−)-Sclareol

  摘要：

  [GRAPHICS]A new route toward puupehenone-related bioactive metabolites from (-)-sclareol, based on the palladium(II)-mediated diastereoselective cyclization of a drimenylphenol, is described. Utilizing this, the first enantiospecific synthesis of the antitumor and antimalarial (-)-15-oxopuupehenol, together with improved syntheses of (+)-puupehenone, (+)-puupehedione, and (+)-15-cyanopuupehenone, were accomplished.

  DOI：

  10.1021/ol047332j

文献信息

• Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads
  作者：Xia Wang、Nvdan Hu、Wenlong Kong、Baoan Song、Shengkun Li

  DOI：10.1016/j.ejmech.2021.113912

  日期：2022.1

  antitumor activities. (+)-Albaconol, (+)-neoalbaconol, and two (+)-yahazunol isomers (24 and 25) proved to be the novel pharmaceutical leads. The probable macromolecular targets were estimated to deliver new information about the biological potentials resident in (+)-yahazunol relevant products. This work also featured the first synthesis of (+)-albaconol and (+)-neoalbaconol, the first biological exploration

  drimane 对苯二酚的多样性通过 (+)-chromazonarol 相关天然产物、异构体和类似物的简便构建显着扩大，以发现新的药物先导物。(+)-chromazonarol 相关（非）天然产物的构效关系通过可编程合成和生物活性引导筛选的协同作用进行描述。(+)-chromazonarol 的第一次不同衍生表明酚羟基是抗真菌作用不可侵犯的要求。(+)-yahazunol 的精确修饰表明羟基的位置对于抗真菌和抗肿瘤活性都至关重要。(+)-Albaconol、(+)-neoalbaconol 和两种 (+)-yahazunol 异构体 ( 24和25) 被证明是新的药物先导。估计可能的大分子靶标可提供有关 (+)-yahazunol 相关产品中存在的生物潜力的新信息。该工作还首次合成了 (+)-albaconol 和 (+)-neoalbaconol，首次对 (+)-dictyvaric acid
• Synthesis and antitumor activity of puupehedione and related compounds
  作者：Alejandro F. Barrero、Enrique J. Alvarez-Manzaneda、Rachid Chahboun、M. Cortés、V. Armstrong

  DOI：10.1016/s0040-4020(99)00992-8

  日期：1999.12

  The first enantiospecific synthesis of bioactive marine puupehedione (2) and related compounds from (−)-sclareol (11) is reported. The antitumor activity of these compounds was assayed and compared with that of the natural products.

  据报道，首次从（-）-香紫苏醇（11）合成了生物活性海洋puupehedione（2）和相关化合物的对映体。测定这些化合物的抗肿瘤活性并将其与天然产物的抗肿瘤活性进行比较。
• NIS–PPh₃: A Selective Reagent for the Spiroannulation of <i>o</i>-Allyl Phenols. Total Synthesis of Corallidictyal D
  作者：M. José Cano、Hanane Bouanou、Rubén Tapia、Esteban Alvarez、Ramón Alvarez-Manzaneda、Rachid Chahboun、Enrique Alvarez-Manzaneda

  DOI：10.1021/jo4014047

  日期：2013.9.20

  Treatment of o-allyl phenols with catalytic NIS–PPh3 affords the corresponding spirodihydrobenzofuran derivatives in high yield with high regio- and total stereoselectivity under mild conditions. These results were utilized to achieve the first total synthesis of the protein kinase C inhibitor corallidictyal D starting from α-ionone.

  用催化性NIS-PPh 3处理邻烯丙基苯酚可在温和条件下以高收率和高区域选择性和总立体选择性提供相应的螺二氢苯并呋喃衍生物。这些结果被用来实现从α-紫罗兰酮开始的蛋白激酶C抑制剂珊瑚D的第一个全合成。
• A New Artificial Cyclase for Polyprenoids:  Enantioselective Total Synthesis of (−)-Chromazonarol, (+)-8-<i>e</i><i>pi</i>-Puupehedione, and (−)-11‘-Deoxytaondiol Methyl Ether
  作者：Hideaki Ishibashi、Kazuaki Ishihara、Hisashi Yamamoto

  DOI：10.1021/ja0472026

  日期：2004.9.1

  pure 3-o-fluorobenzyloxy-2-hydroxy-2'-(p-methoxybemzyl)-1,1'-binaphthyl.SnCl4, which is effective for the enantioselective cyclization of 2-(polyprenyl)phenol derivatives to afford polycyclic terpenoids bearing a chroman skeleton such as (-)-chromazonarol, (+)-8-epi-puupehedione, a key synthetic intermediate of (+)-wiedendiol, and (-)-11'-deoxytaondiol methyl ether.

  本文介绍了一种新型人工环化酶，光学纯的 3-o-fluorobenzyloxy-2-hydroxy-2'-(p-methoxybemzyl)-1,1'-binaphthyl.SnCl4，可有效地对映选择性环化 2-(polyprenyl ) 苯酚衍生物，提供带有色满骨架的多环萜类化合物，例如 (-)-chromazonarol、(+)-8-epi-puupehedione、(+)-wiedendiol 的关键合成中间体和 (-)-11'-deoxytaondiolmethyl醚。
• First Enantiospecific Synthesis of the Antitumor Marine Sponge Metabolite (−)-15-Oxopuupehenol from (−)-Sclareol
  作者：E. J. Alvarez-Manzaneda、R. Chahboun、I. Barranco Pérez、E. Cabrera、E. Alvarez、R. Alvarez-Manzaneda

  DOI：10.1021/ol047332j

  日期：2005.4.14

  [GRAPHICS]A new route toward puupehenone-related bioactive metabolites from (-)-sclareol, based on the palladium(II)-mediated diastereoselective cyclization of a drimenylphenol, is described. Utilizing this, the first enantiospecific synthesis of the antitumor and antimalarial (-)-15-oxopuupehenol, together with improved syntheses of (+)-puupehenone, (+)-puupehedione, and (+)-15-cyanopuupehenone, were accomplished.